Menopausal asthma: A new biological phenotype?

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 10, 2010, Pages 1306-1312

  Foschino Barbaro, M P ^a   Costa, V R ^b   Resta, O ^b   Prato, R ^c   Spanevello, A ^a   Palladino, G P ^a   Martinelli, D ^b   Carpagnano, G E ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c IRCCS   (Italy)

Author keywords

asthma; breath condensate; eosinophils; hormones; menopause; neutrophils; nitric oxide; pH

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ESTRADIOL; INTERLEUKIN 6; LEUKOTRIENE E4; NITRIC OXIDE;

ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; INFLAMMATORY CELL; LUNG FUNCTION; MAJOR CLINICAL STUDY; MENOPAUSAL ASTHMA; MENOPAUSAL SYNDROME; NEUTROPHIL; PH MEASUREMENT; PHENOTYPE; PREMENOPAUSE; PRIORITY JOURNAL;

ASTHMA; CASE-CONTROL STUDIES; EOSINOPHILS; EXHALATION; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; INFLAMMATION; INTERLEUKIN-4; LEUKOTRIENE E4; MENOPAUSE; MIDDLE AGED; NEUTROPHILS; NITRIC OXIDE; PHENOTYPE; PREMENOPAUSE; SPUTUM;

EID: 77956428045     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02314.x     Document Type: Article

References (52)

1. Lange P, Parner J, Prescott E, Ulrik CS, Vestbo J. Exogenous female sex steroid hormones and risk of asthma and asthma-like symptoms: a cross sectional study of the general population. Thorax 2001 56 : 613 662.
2. Foschino Barbaro MP, De Tullio R, Cagnazzo MG, Depalo A, Carpagnano GE, Spanevello A et al. Asthma and the menopause. Ageing Lung 2006 1 : 13 19.
3. Real FG, Svanes C, Omenaas ER, Antò JM, Plana E, Jarvis D et al. Lung function, respiratory symptoms, and the menopausal transition. J Allergy Clin Immunol 2008 121 : 72 80.e3. Epub 2007 Oct 29.
4. Becklake MR, Kauffmann F. Gender differences in airway behaviour over the human life span. Thorax 1999 54 : 1119 1138.
5. Real FG, Svanes C, Omenaas ER, Antò JM, Plana E, Janson C et al. Menstrual irregularity and asthma and lung function. J Allergy Clin Immunol 2007 120 : 557 564.
6. Salam MT, Wenten M, Gilliland FD. Endogenous and exogenous sex steroid hormones and asthma and wheeze in young women. J Allergy Clin Immunol 2006 117 : 1001 1007.
7. Gómez Real F, Svanes C, Björnsson EH, Franklin KA, Gislason D, Gislason T et al. Hormone replacement therapy, body mass index, and asthma in perimenopausal women: a cross sectional survey. Thorax 2006 61 : 34 40.
8. Svanes C, Real FG, Gislason T, Jansson C, Jögi R, Norrman E et al. Association of asthma and hay fever with irregular menstruation. Thorax 2005 60 : 445 450.
9. Troisi RJ, Speizer FE, Willett WC, Trichopoulos D, Rosner B. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study. Am J Respir Crit Care Med 1995 152 (4 Pt 1 1183 1188.
10. Skobeloff EM, Spivey WH, St Clair SS, Schoffstall JM. The influence of age and sex on asthma admissions. JAMA 1992 268 : 3437 3440.
11. Elliasson O. The male-female ratio of hospital admissions for asthma. Am Rev Respir Dis 1985 131 (Pt 2 A110.
12. Rees L. An aetiological study of premenstrual asthma. J Psychosom Res 1963 52 : 191 197.
13. Hanley SP. Asthma variation with menstruation. Br J Dis Chest 1981 75 : 306 308.
14. Gibbs CJ, Coutts II, Lock R, Finnegan OC, White RJ. Premenstrual exacerbation of asthma. Thorax 1984 39 : 833 836.
15. Eliasson O, Scherzer HH, DeGraff AC Jr. Morbidity in asthma in relation to the menstrual cycle. J Allergy Clin Immunol 1986 77 (1 Pt 1 87 94.
16. Bonner JR. The epidemiology and natural history of asthma. Clin Chest Med 1984 5 : 557 565. Review.
17. Durwood BJ. Concomitant problems with asthma. Clin Chest Med 1983 5 : 557 565.
18. Myers JR, Sherman CB. Should supplemental estrogens be MSDN as steroid-sparing agents in asthmatics women? Chest 1994 106 : 318 319.
19. Ten Brinke A, Ouwerkerck ME, Zwindermann AH, Spiuhoven P, Bel EH. Psychopathology in patients with severe asthma is associated with increased health care utilization. Am J Respir Crit Care Med 2001 163 : 1093 1096.
20. Kohler PO. Clinical endocrinology. New York : John Wiley, 1986.
21. Della Torre F, Cassani L, Segale M et al. Asma ed orticaria nell'anziano: ruolo degli ormoni ipofiso-gonadici in menopausa. Rassegna Geriatria 1988 24 : 165 171.
22. Rubio Ravelo L, Gago Rodríguez B, Almirall Collazo JJ, Bell Heredia L, Fernández Fernández L. Comparative study of progesterone, estradiol and cortisol concentrations in asthmatic and nonasthmatic women. Allergol Immunopathol (Madr) 1988 16 : 263 266.
23. Farina F, Colombi S, Cantore R, Pastore N, Centanni F, Galimberti M. Study of hypophyseal and gonadal hormones and cases of postmenopausal occurrence of bronchial asthma. Minerva Med 1986 77 : 243 247.
24. Balzano G, Fuschillo S, Melillo G et al. Asthma and sex hormones. Allergy 2001 56 : 13 20.
25. Pfeilschifter J, Kodiz R, Pfohl M et al. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002 23 : 90 119.
26. Balzano G, Fuschillo S, De Angelis E, Gaudiosi C, Mancini A, Caputi M. Persistent airway inflammation and high exacerbation rate in asthma that starts at menopause. Monaldi Arch Chest Dis 2007 67 : 135 141.
27. Horváth I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005 26 : 523 548.
28. Carpagnano GE, Foschino-Barbaro MP, Spanevello A, Resta O, Carpagnano F, Mulé G et al. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer. Am J Respir Crit Care Med 2008 177 : 337 341.
29. Gogate S, Katial R. Pediatric biomarkers in asthma: exhaled nitric oxide, sputum eosinophils and leukotriene E4. Curr Opin Allergy Clin Immunol 2008 8 : 154 157.
30. Guidelines from the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). 2007. Available from: http://www. ginasthma.org.
31. Dreborg S. Skin testing. The safety of skin tests and the information obtained from using different methods and concentrations of allergen. Allergy 1993 48 : 473 475.
32. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R et al. Interpretative strategies for lung function tests. Eur Respir J 2005 26 : 948 968.
33. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999 8 : 135 160.
34. Montuschi P, Barnes PJ. Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol 2002 109 : 615 620.
35. Profita M, La Grutta S, Carpagnano E, Riccobono L, Di Giorgi R, Bonanno A et al. Noninvasive methods for the detection of upper and lower airway inflammation in atopic children. J Allergy Clin Immunol 2006 118 : 1068 1074. Epub 2006 Sep 12.
36. Borrill Z, Starkey C, Vestbo J, Singh D. Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease. Eur Respir J 2005 25 : 269 274. (Pubitemid 40246526)
37. American Thoracic Society; European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005 171 : 912 930.
38. Kharitonov SA, Gonio F, Kelly C, Meah S, Barnes PJ. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J 2003 21 : 433 438.
39. Spanevello A, Gonfalonieri M, Sulotto F et al. Induced sputum cellularity. Am J Respir Crit Care Med 2000 162 : 1172 1174.
40. Carpagnano GE, Barnes PJ, Francis J, Wilson N, Bush A, Kharitonov SA. Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation? Chest 2004 125 : 2005 2010.
41. van Veen IH, Sterk PJ, Schot R, Gauw SA, Rabe KF, Bel EH. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur Respir J 2006 27 : 951 956. Epub 2006 Jan 30.
42. Shibata A, Katsunuma T, Tomikawa M, Tan A, Yuki K, Akashi K et al. Increased leukotriene E4 in the exhaled breath condensate of children with mild asthma. Chest 2006 130 : 1718 1722.
43. Brunetti L, Francavilla R, Tesse R, Strippoli A, Polimeno L, Loforese A et al. Exhaled breath condensate pH measurement in children with asthma, allergic rhinitis and atopic dermatitis. Pediatr Allergy Immunol 2006 17 : 422 427.
44. Pavord ID, Shaw D. The use of exhaled nitric oxide in the management of asthma. J Asthma 2008 45 : 523 531. Review.
45. The ENFUMOSA Study Group. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J 2003 22 : 470 477.
46. Rabinovitch N. Urinary leucotriene E4. Immunol Allergy Clin North Am 2007 27 : 651 664. vii
47. Cai C, Yang J, Hu S, Zhou M, Guo W. Relationship between urinary cysteinyl leukotriene E4 levels and clinical response to antileukotriene treatment in patients with asthma. Lung 2007 185 : 105 112. Epub 2007 Mar 28.
48. Sampson AP, Castling DP, Green CP, Price JF. Persistent increase in plasma and urinary leucotrienes after acute asthma. Arch Dis Child 1995 73 : 221 225.
49. Laitinen LA, Laitinen A, Haahtela T, Vikka V, Spur BW, Lee TH. Leucotriene E-4 and granulocytic infiltration into asthmatic airways. Lancet 1993 341 : 989 990.
50. Montuschi P, Mondino C, Koch P, Barnes PJ, Ciabattoni G. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma. J Allergy Clin Immunol 2006 118 : 347 353. Epub 2006 Jul 3.
51. Carpagnano GE, Foschino Barbaro MP, Resta O, Gramiccioni E, Valerio NV, Bracciale P et al. Exhaled markers in the monitoring of airways inflammation and its response to steroid's treatment in mild persistent asthma. Eur J Pharmacol 2005 519 : 175 181.
52. Strunk RC, Szefler SJ, Phillips BR, Zeiger RS, Chinchilli VM, Larsen G et al. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol 2003 112 : 883 892.